Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Of the 16 patients, 8 patients are considered well-controlled and 8 patients have HCT levels over 45% at baseline.
To date, divesiran has been observed to be well tolerated with no major safety issues.
Posted In: SLN